Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings
Recruiting · NCT07155707 · Interventional (participants receive a specific treatment) · Lead sponsor: Stanford University
View the official record on ClinicalTrials.gov →Interventions studied
Standard VideoconferencingTeleo
What this trial is about
This Phase II trial will examine engagement in telehealth for children undergoing psychotherapy. Specifically, the trial will examine patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.
Who can take part
Age range
5 Years to 14 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Diagnosed with a mood and/or anxiety disorder
- Have proficiency to participate in psychotherapy in English
- Scheduled to begin therapy at one of the study sites
- RCADS score \> 65
Exclusion criteria
- \- Comorbid diagnosis of intellectual disability, autism spectrum disorder, psychotic disorders, high-risk suicidal behaviors requiring immediate hospitalization, substance use disorders, or other physical or mental condition that would prohibit them from engaging in telehealth settings.
Where it is running
4 locations listed across 1 US state.
- Ohana Center for Child and Adolescent Behavioral Health - Monterey, California, United States
- Ohana Center for Child and Adolescent Behavioral Health - Monterey, California, United States
- Stanford University - Stanford, California, United States
- Stanford University - Stanford, California, United States